{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:55:53Z","timestamp":1781510153297,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.berh.2026.102155","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:47:22Z","timestamp":1778586442000},"page":"102155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Axial spondyloarthritis: Moving beyond cytokine based therapies to cellular targets and advanced therapeutics"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2274-7944","authenticated-orcid":false,"given":"Surbhi","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4337-0696","authenticated-orcid":false,"given":"Rahul","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9283-7462","authenticated-orcid":false,"given":"Mohamad","family":"Bittar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2130-1246","authenticated-orcid":false,"given":"Atul","family":"Deodhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2026.102155_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0167-5699(90)90051-A","article-title":"Guilt by association: HLA-B27 and ankylosing spondylitis","volume":"11","author":"Benjamin","year":"1990","journal-title":"Immunol Today"},{"issue":"7836","key":"10.1016\/j.berh.2026.102155_bib2","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0140-6736(73)91091-X","article-title":"Reiter's disease and HL-A 27","volume":"302","author":"Brewerton","year":"1973","journal-title":"Lancet Lond Engl"},{"issue":"26","key":"10.1016\/j.berh.2026.102155_bib3","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1056\/NEJMra1406182","article-title":"Ankylosing spondylitis and axial spondyloarthritis","volume":"374","author":"Taurog","year":"2016","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.berh.2026.102155_bib4","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/acr.24025","article-title":"2019 update of the American college of rheumatology\/spondylitis association of America\/spondyloarthritis research and treatment network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis","volume":"71","author":"Ward","year":"2019","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.berh.2026.102155_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/BOR.0000000000000714","article-title":"Physical therapy in axial spondyloarthritis: guidelines, evidence and clinical practice","volume":"32","author":"Martey","year":"2020","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2026.102155_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41584-022-00761-z","article-title":"Treatment of axial spondyloarthritis: an update","volume":"18","author":"Danve","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2026.102155_bib7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.semarthrit.2015.08.003","article-title":"Exercise for ankylosing spondylitis: an evidence-based consensus statement","volume":"45","author":"Millner","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2026.102155_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-002168","volume":"8","author":"Gwinnutt","year":"2022","journal-title":"RMD Open"},{"issue":"10","key":"10.1016\/j.berh.2026.102155_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103638","article-title":"Treatment strategies for spondyloarthritis: implementation of precision medicine \u2013 or \u201cone size fits all\u201d concept?","volume":"23","author":"Proft","year":"2024","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2026.102155_bib10","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3906\/sag-1401-79","article-title":"Treatment of ankylosing spondylitis","volume":"45","author":"Sari","year":"2015","journal-title":"Turk J Med Sci"},{"issue":"4","key":"10.1016\/j.berh.2026.102155_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003461","article-title":"Difficult-to-treat axial spondyloarthritis is associated with psoriasis, peripheral involvement and comorbidities: results of an observational nationwide study","volume":"9","author":"Fakih","year":"2023","journal-title":"RMD Open"},{"issue":"Supplement_4","key":"10.1016\/j.berh.2026.102155_bib12","doi-asserted-by":"crossref","first-page":"iv79","DOI":"10.1093\/rheumatology\/keaa435","article-title":"Treatment strategies in axial spondyloarthritis: what, when and how?","volume":"59","author":"Fragoulis","year":"2020","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2026.102155_bib13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/art.39474","article-title":"Brief report: six-week treatment of axial spondyloarthritis patients with an optimal dose of nonsteroidal antiinflammatory drugs: early response to treatment in signal intensity on magnetic resonance imaging of the sacroiliac joints","volume":"68","author":"Varkas","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102155_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/rheumatology\/kew367","article-title":"Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis","volume":"56","author":"Baraliakos","year":"2017","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2026.102155_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.47360\/1995-4484-2024-65-80","article-title":"Effectiveness and safety of BCD180, anti-TRBV9+ T-lymphocytes monoclonal antibody in patients with active radiographic axial spondyloarthritis: 36-week results of double-blind randomized placebo-controlled phase II clinical study ELEFTA","volume":"62","author":"Nasonov","year":"2024","journal-title":"Rheumatol Sci Pract"},{"issue":"1","key":"10.1016\/j.berh.2026.102155_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000396","article-title":"Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS\/EULAR recommendations for the management of axial spondyloarthritis","volume":"3","author":"Sepriano","year":"2017","journal-title":"RMD Open"},{"issue":"4","key":"10.1016\/j.berh.2026.102155_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-057850","article-title":"Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain","volume":"12","author":"Benavent","year":"2022","journal-title":"BMJ Open"},{"issue":"8","key":"10.1016\/j.berh.2026.102155_bib18","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/annrheumdis-2020-219601","article-title":"Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study","volume":"80","author":"Deodhar","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2026.102155_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.31138\/mjr.34.2.129","article-title":"JAK inhibitors for the treatment of axial spondyloarthritis","volume":"34","author":"Klavdianou","year":"2023","journal-title":"Mediterr J Rheumatol"},{"issue":"7941","key":"10.1016\/j.berh.2026.102155_bib20","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41586-022-05501-7","article-title":"Autoimmunity-associated T cell receptors recognize HLA-B\u221727-bound peptides","volume":"612","author":"Yang","year":"2022","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.berh.2026.102155_bib21","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1038\/s41591-023-02613-z","article-title":"Targeted depletion of TRBV9+ T cells as immunotherapy in a patient with ankylosing spondylitis","volume":"29","author":"Britanova","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.berh.2026.102155_bib22","article-title":"Bispecific T cell-engaging antibodies to target TRBV9+ autoreactive T cells in axial spondyloarthritis","author":"Glavaris","year":"2025","journal-title":"Eular\u00a6 Europ Allianca Assoc Rheumatol"},{"key":"10.1016\/j.berh.2026.102155_bib23","author":"Holec"},{"key":"10.1016\/j.berh.2026.102155_bib24","author":"Paley"},{"issue":"3","key":"10.1016\/j.berh.2026.102155_bib25","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/art.41129","article-title":"Altered cytotoxicity profile of CD 8+ T cells in ankylosing spondylitis","volume":"72","author":"Gracey","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.berh.2026.102155_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112715","article-title":"Single cell immune profiling in ankylosing spondylitis reveals resistance of CD8+ T cells to immune exhaustion","volume":"28","author":"Tang","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.berh.2026.102155_bib27","author":"Qaiyum"},{"issue":"1","key":"10.1016\/j.berh.2026.102155_bib28","doi-asserted-by":"crossref","DOI":"10.1080\/15476278.2022.2164159","article-title":"Clinical manufacturing of regulatory T cell products for adoptive cell therapy and strategies to improve therapeutic efficacy","volume":"19","author":"Baron","year":"2023","journal-title":"Organogenesis"},{"issue":"7","key":"10.1016\/j.berh.2026.102155_bib29","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.berh.2026.102155_bib30","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","article-title":"Treg cell-based therapies: challenges and perspectives","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.berh.2026.102155_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1166135","article-title":"Opportunities for Treg cell therapy for the treatment of human disease","volume":"14","author":"Bluestone","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2026.102155_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1626085","article-title":"Navigating the manufacturing, testing and regulatory complexities of regulatory T cells for adoptive cell therapy","volume":"16","author":"Pikor","year":"2025","journal-title":"Front Immunol"},{"issue":"10416","key":"10.1016\/j.berh.2026.102155_bib33","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0140-6736(23)01126-1","article-title":"CAR T-cell therapy in autoimmune diseases","volume":"402","author":"Schett","year":"2023","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.berh.2026.102155_bib34","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2024.19462","article-title":"CAR T cells and T-Cell therapies for cancer: a translational science review","volume":"332","author":"Brudno","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.berh.2026.102155_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1613502","article-title":"Breaking boundaries in ankylosing spondylitis: how innovative cell therapies reshape immunity, drive cutting-edge advances, and face future challenges","volume":"16","author":"Ke","year":"2025","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.berh.2026.102155_bib36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41571-024-00903-0","article-title":"Current understanding and management of CAR T cell-associated toxicities","volume":"21","author":"Brudno","year":"2024","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694226000409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694226000409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:46:45Z","timestamp":1781509605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694226000409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1521694226000409"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2026.102155","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Axial spondyloarthritis: Moving beyond cytokine based therapies to cellular targets and advanced therapeutics","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2026.102155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102155"}}